CAS: 204318-14-9 - 2,2',2''-[10-(2-{[(2R)-1-{[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-{[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl}-16-(4-hydroxybenzyl)-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-

Fórmula: C₆₅H₉₂N₁₄O₁₈S₂

InChI: InChI=1/C65H92N14O18S2/c1-39(81)51(36-80)72-64(96)53-38-99-98-37-52(73-60(92)48(28-41-10-4-3-5-11-41)68-54(84)32-76-20-22-77(33-55(85)86)24-26-79(35-57(89)90)27-25-78(23-21-76)34-56(87)88)63(95)70-49(29-42-15-17-44(83)18-16-42)61(93)71-50(30-43-31-67-46-13-7-6-12-45(43)46)62(94)69-47(14-8-9-19-66)59(91)75-58(40(2)82)65(97)74-53/h3-7,10-13,15-18,31,39-40,47-53,58,67,80-83H,8-9,14,19-30,32-38,66H2,1-2H3,(H,68,84)(H,69,94)(H,70,95)(H,71,93)(H,72,96)(H,73,92)(H,74,97)(H,75,91)(H,85,86)(H,87,88)(H,89,90)/t39-,40-,47+,48-,49+,50-,51-,52+,53+,58+/m1/s1

DOTA-(Tyr³)-Octreotide

CAS: 204318-14-9

Somatostatin analog for tumor scintigraphy and radionuclide therapy.

• Fórmula: C₆₅H₉₂N₁₄O₁₈S₂
• Pureza: 98.4%
• Cor e Forma: White
• Peso molecular: 1421.66

L-Cysteinamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide

CAS: 204318-14-9

• Fórmula: C₆₅H₉₂N₁₄O₁₈S₂
• Pureza: 96%
• Cor e Forma: Solid
• Peso molecular: 1421.6390

Edotreotide

CAS: 204318-14-9

Edotreotide (SMT-487) is an Indicator and Reagent. It also is used in the Diagnosis and …

• Fórmula: C₆₅H₉₂N₁₄O₁₈S₂
• Pureza: 96.95%
• Cor e Forma: Solid
• Peso molecular: 1421.64

Edotreotide trifluoroacetate

CAS: 204318-14-9

Edotreotide trifluoroacetate is a diagnostic agent that is used to diagnose hepatic steatosis. It is …

• Fórmula: C₆₅H₉₂N₁₄O₁₈S₂·xC₂HF₃O₂
• Pureza: Min. 95%
• Cor e Forma: Powder